Bionews Clinical
  • About
  • Sponsors
  • Patient Community
  • Clinical News
  • Contact
Select Page

Clinical Trial Shows TD139 as a Promising Therapy Against Pulmonary Fibrosis, Maker Says

Clinical trial results indicate that inhaled TD139 is an effective, safe and well-tolerated treatment for idiopathic pulmonary fibrosis (IPF), its maker, Galecto Biotech AB, has reported. The phase 1b/2a clinical trial (NCT02257177) was divided into two parts. Part 1...

Recent Posts

  • Brittany’s Story
  • Michael’s Story
  • Brad’s Story
  • Kevin’s Story
  • Charlene’s Story

Recent Comments

    Connect with BioNews Clinical

    Are you a clinical research industry contributor interested in partnering with BioNews Clinical? Please enter your information below and we’ll be in touch.

    Are you a patient or family member interested in participating in a clinical trial? Tell us more about you using the form below, and you’ll be added to our mailing list.

    * All fields are required.

    By submitting this form I agree to receive communications from BioNews Clinical, and have read and agree to the BioNews Clinical privacy policy.

    Thank you for contacting us. We look forward to connecting with you to move research forward, faster!

    Submit

    • Careers
    • Terms of Service
    • Privacy Policy
    • Contact
    • Follow
    • Follow

    BioNews Clinical, LLC

    3 W Garden St
    Suite 700
    Pensacola, FL 32502

    [email protected]
    1.800.936.1363

    © 2021. All rights reserved.